BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28980442)

  • 1. Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy.
    Lausch A; Lamey M; Zeng GG
    J Appl Clin Med Phys; 2017 Nov; 18(6):137-141. PubMed ID: 28980442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated prediction of dosimetric eligibility of patients with prostate cancer undergoing intensity-modulated radiation therapy using a convolutional neural network.
    Kajikawa T; Kadoya N; Ito K; Takayama Y; Chiba T; Tomori S; Takeda K; Jingu K
    Radiol Phys Technol; 2018 Sep; 11(3):320-327. PubMed ID: 30109572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application programming in C# environment with recorded user software interactions and its application in autopilot of VMAT/IMRT treatment planning.
    Wang H; Xing L
    J Appl Clin Med Phys; 2016 Nov; 17(6):189-203. PubMed ID: 27929493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
    Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
    Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.
    Stanley DN; Popp T; Ha CS; Swanson GP; Eng TY; Papanikolaou N; Gutiérrez AN
    Pract Radiat Oncol; 2015; 5(6):e625-33. PubMed ID: 26419443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy in patients with prostate cancer: a meta-analysis.
    Ren W; Sun C; Lu N; Xu Y; Han F; Liu YP; Dai J
    J Appl Clin Med Phys; 2016 Nov; 17(6):254-262. PubMed ID: 27929498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy.
    Buschmann M; Sharfo AWM; Penninkhof J; Seppenwoolde Y; Goldner G; Georg D; Breedveld S; Heijmen BJM
    Strahlenther Onkol; 2018 Apr; 194(4):333-342. PubMed ID: 29270648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow.
    Orlandini LC; Coppola M; Fulcheri C; Cernusco L; Wang P; Cionini L
    Radiat Oncol; 2017 Apr; 12(1):78. PubMed ID: 28454559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric-modulated arc therapy planning using multicriteria optimization for localized prostate cancer.
    Ghandour S; Matzinger O; Pachoud M
    J Appl Clin Med Phys; 2015 May; 16(3):5410. PubMed ID: 26103500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy.
    Bell K; Heitfeld M; Licht N; Rübe C; Dzierma Y
    Radiat Oncol; 2017 Jan; 12(1):7. PubMed ID: 28069053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully automated volumetric modulated arc therapy plan generation for prostate cancer patients.
    Voet PW; Dirkx ML; Breedveld S; Al-Mamgani A; Incrocci L; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1175-9. PubMed ID: 24529714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helical tomotherapy-based hypofractionated radiotherapy for prostate cancer: a report on the procedure, dosimetry and preliminary clinical outcome.
    Murthy V; Krishnatry R; Mallik S; Master Z; Mahantshetty U; Shrivastava S
    J Cancer Res Ther; 2013; 9(2):253-60. PubMed ID: 23771369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
    Liu F; Ahunbay E; Lawton C; Li XA
    Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.